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Abstract
Background: Health Related Quality of Life (HRQoL) studies on children with chronic illness such
as thalassaemia are limited. We conducted the first study to investigate if children with thalassaemia
have a lower quality of life in the four dimensions as measured using the PedsQL 4.0 generic Scale
Score: physical, emotional, social and role (school) functioning compared to the healthy controls
allowing for age, gender, ethnicity and household income.
Methods: The PedsQL 4.0 was administered to children receiving blood transfusions and
treatments at Hospital Kuala Lumpur, Malaysia using PedsQL 4.0 generic Scale Score. Accordingly,
the questionnaire was also administered to a control group of healthy school children. Socio-
demographic data were also collected from patients and controls using an interview schedule
designed for the study.
Results: Of the 96 thalassaemia patients approached, 78 gave consent to be interviewed giving a
response rate of 81.3%. Out of 235 healthy controls approached, all agreed to participate giving a
response rate of 100%. The mean age for the patients and schoolchildren is 11.9 and 13.2 years
respectively. The age range for the patients and the schoolchildren is between 5 to 18 years and 7
to 18 years respectively. After controlling for age and demographic background, the thalassaemia
patients reported having significantly lower quality of life than the healthy controls.
Conclusion: Thalassaemia has a negative impact on perceived physical, emotional, social and
school functioning in thalassaemia patients which was also found to be worse than the children's
healthy counterparts. Continuing support of free desferal from the Ministry of Health should be
given to these patients. More understanding and support especially from health authorities, school
authorities and the society is essential to enhance their quality of life.
Background
Thalassaemia is a genetic blood disorder which can be
fatal if proper treatment is not received. It is characterised
by partial or no production of alpha or beta globin chains
which form part of the structure of the haemoglobin in
the red blood cells [1]. Thalassaemia is an increasingly
serious public health problem throughout the Mediterra-
nean region, the Middle East, the Indian subcontinent
and South East Asia [2,3]. In Malaysia, it occurs mainly in
the Malays and Chinese Malaysians [4]. The Ministry of
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babies are born with thalassaemia each year [5]. George et
al [4] estimated that there are about 5,600 patients with
blood transfusion dependent beta thalassaemia in Malay-
sia.
Children with thalassaemia appear well at birth but
develop anaemia that becomes progressively worse due to
the partial or total absence of haemoglobin. If left
untreated, this can result in early deaths [2,6]. For those
children that do survive, this condition has serious impli-
cations for the health related quality of life of children.
The children typically, have to undergo blood transfu-
sions at least once a month depending on the severity of
the illness. This means they have to attend the hospital
which sometimes takes a whole day. They also have to get
desferal injections for iron chelation therapy to remove
excess iron in their blood from the blood transfusions
[2,6,7].
Health Related Quality of Life (HRQoL) measurement is
a multidimensional concept that focuses on the impact of
the disease and its treatment on the well being of an indi-
vidual. The measures are seen as ways of capturing
patients' perspectives of their disease and treatment, their
perceived need for healthcare and their preferences for
treatment and disease outcomes [8]. A systematic review,
however, reports of limited use of HRQoL measures in
paediatric clinical trials or clinic practice [9]. The review
identified 18 trials which include assessment of HRQoL
on a variety of paediatric diseases but none on Thalassae-
mia. This is surprising given the nature of the illness.
An extensive and rigorous search on websites and elec-
tronic databases by the team found one paper on the
HRQoL of adults with thalassaemia and one for children.
Most of the research on thalassaemia involves interviews
with patients, carers, nurses and doctors and the focus was
on coping strategies for thalassaemia patients and their
parents, the attitudes and expectations of these patients,
counselling strategies for thalassaemia patients, parents
and siblings and screening programmes for thalassaemia.
A recent study on adults with thalassaemia suggests that
treatment and cultural differences did not have a major
effect on the Quality of life in Cypriot thalassaemia
patients [10]. The research was conducted in a well estab-
lished resource centre and 212 adult patients were
involved. Another study on children compared the quality
of life of patients with thalassaemia intermedia to thalas-
saemia major and discovered that transfusion – independ-
ent thalassaemia patients also suffer impairments in their
quality of life [11]. The team suggested that all patients
with thalassaemia undergo QoL assessment so that inter-
ventions focused on affected domain can be imple-
mented. As a result of the limited research on the HRQoL
of thalassaemia patients in particular children, the aim of
this study was to investigate if the HRQoL thalassaemia
patients is worse than the HRQoL of healthy children in
the essential core domains for pediatric HRQoL measure-
ment: physical functioning, emotional functioning, social
functioning and school functioning.
Methods
This was a cross sectional design study in Kuala Lumpur,
Malaysia. For sample size, the number of cases was lim-
ited by availability to less than 100 and we oversampled
the controls to maintain power. Norman et al [12] have
shown that for many quality of life scores an effect size of
about 0.5 SDs is reasonable and for this, one should need
64 cases and 64 controls for at least 80% power at 5% sig-
nificance level [13].
The patients interviewed were receiving blood transfu-
sions and treatments at the Paediatric Institute, Hospital
Kuala Lumpur in the period May 2005 to August 2005.
The patients were approached as they come in for their
blood transfusions scheduled at the Institute. The study
was approved by the Hospital Ethics Committee. Chil-
dren with thalassaemia come in to the Day Care Centre at
the Institute for their blood transfusions and treatments.
Most of them have been getting their treatments at the
Institute since they were diagnosed as having thalassae-
mia. Previously, patients had to buy their own desferal for
their iron chelation therapy. Patients are known to miss
their desferal injections because they could not afford to
buy desferal. However, since December 2004, six months
before this study was conducted, the Paediatric Institute
was the first Government hospital in Malaysia to provide
desferal to all patients getting treatment there. Further
inclusion criteria were written informed consent, aged
between 5 to 18 years and patients who could read, write
and understand Malay, English or Mandarin.
For the healthy controls, the questionnaires were admin-
istered to children in the neighbouring schools between 7
to 18 years of age. Permission to administer the question-
naires was granted by the Economic Planning Unit at the
Prime Minister's Department and the Ministry of Educa-
tion of Malaysia. Thus this study investigates the HRQoL
of children with thalassaemia six months after getting
proper treatment (blood transfusions and desferal) at the
Institute.
Research instrument
HRQoL was assessed with the PedsQL 4.0 Generic Core
Scales. This instrument has 23-items that are designed to
measure the core dimensions of health as delineated by
WHO. The PedsQoL 4.0 encompasses the essential core
domains for paediatric HRQoL measurement: 1) Physical
Functioning (8 items), 2) Emotional Functioning (5Page 2 of 8
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Functioning (5 items). It consists of developmentally
appropriate forms for ages 2–4, 5–7, 8–12 and 13–18
years. The reliability, validity, responsiveness, and practi-
cality of the PedsQL Generic Core Scales have been
assessed in both physically healthy paediatric populations
and in paediatric acute and chronic health conditions. The
internal consistency reliability of the PedsQL 4.0 Generic
Core Scale approached 0.90 for self-report [14-16]. Miss-
ing data were also minimal. Item response distributions
were across the full scale range, with no floor effects, and
minimal ceiling effects. The validity of the PedsQL
Generic Core Scales has been demonstrated through
known group comparisons, and correlations with other
measures of disease burden. User agreement was signed
with MAPI Research Institute, Lyon, France prior to using
the questionnaires. PedsQL 4.0 Generic Core Scales has
also been translated into many languages and we use the
UK English, Malaysian Language and Chinese Mandarin
versions as appropriate.
Statistical analysis
The assumptions of normality and homoscedasticity were
investigated and found plausible [17,18]. Differences in
the variables between thalassaemia patients and healthy
controls were tested using the independent t-test and Chi
Square Test. Since the controls are slightly older, we also
conducted a matched control analysis on the two groups
by age and gender. A paired sample t-test was used to test
the differences between the pairs. We further exclude
patients who have had bone marrow transplants in our
analysis to compare results. We then used multiple linear
regressions to compare the patients and controls for the
different domains in PedsQL 4.0, adjusting for age, gen-
der, ethnicity and household income. We also tested for
interactions between these covariates on the outcome var-
iable. For all the tests conducted, a p value of ≤ 0.05 is con-
sidered statistically significant.
Results
A total of 96 patients receiving treatments at the Institute
were approached out of 140 on the record. 14 (14.6%)
did not fit inclusion criteria (age, did not understand
Malay, Mandarin or English), 1 refused (1.0%), 3 (3.1%)
quit halfway and 78 completed the interview. This gives a
response rate of 81.3% for the thalassaemia patients. The
three patients who quit halfway were restless and decided
not to continue with the interviews. Of the 235 question-
naires distributed to the healthy controls, all of them
answered and responded to the questionnaires, giving a
100% response rate.
Table 1 summarises the demographic variables of the 78
thalassaemia patients and 235 healthy controls. The
healthy controls are slightly older, have higher education
and are better off than the patient group. The mean age of
the healthy controls was 13.2 years old and the age range
was between 7 to 18 years old. The mean age of the
patients is 11.9 years old and the age range was between 5
to 18 years old. 37 out of 78 patients (47.4%) came from
families with household income of less than RM1500. Of
the 235 participants in healthy group, only 68 (29%)
came from families with household income of less than
RM1500. Both the thalassaemia patients and controls
Table 1: Demographic Characteristics of Thalassaemia patients
Thalassaemia 
Patients 
(n = 78)
Healthy 
Controls 
(n = 235)
P values
Age, y+ 11.95 (4.3) 13.2 (2.8) p = 0.004
Gender* p = 0.311
Female 34 (43.6) 118 (50.2)
Range
5–7 years 8 (18.2) 7 (6.0)
8–12 years 19 (43.2) 47 (40.2)
13–18 years 17 (38.6) 63 (53.8)
Male 44 (56.4) 117 (49.8)
Range
5–7 years 6 (17.6) 6 (5.1)
8–12 years 14 (41.2) 21 (17.8)
13–18 years 14 (41.2) 91 (77.1)
Ethnicity*
Malay 56 (71.8) 136 (57.9) p = 0.001
Chinese 16 (20.5) 53 (22.5)
Indian 1 (1.3) 40 (17.0)
Others 5 (6.4) 6 (2.6)
Religion* p = 0.001
Islam 57 (73.1) 138 (58.7)
Buddha 14 (17.9) 44 (18.7)
Hindu 1 (1.3) 34 (14.5)
Christian 2 (2.6) 17 (7.2)
Others 4 (5.1) 2 (0.9)
Educational* Level p < 0.001
Not at School 4 (5.1) 0 (0.0)
Pre School 5 (6.4) 0 (0.0)
Primary (1–6) 38 (48.7) 81 (34.5)
Secondary (1–5) 18 (23.1) 150 (63.8)
Sixth Form 2 (2.6) 4 (1.7)
Finish School 11 (14.1) 0 (0.0)
Household* Income (RM) p < 0.001
<500 2 (2.6) 3 (1.3)
500–1000 16 (20.4) 27 (11.5)
1000–1500 19 (24.4) 38 (16.2)
1500–2000 19 (24.4) 25 (10.6)
>2000 21 (26.9) 138 (58.7)
Missing 1 (1.3) 4 (1.7)
* Values are presented as number (percentage) unless otherwise 
indicated. + Data given as Mean (SD). RM is an acronym for Malaysian 
Ringgit.Page 3 of 8
(page number not for citation purposes)
Health and Quality of Life Outcomes 2006, 4:39 http://www.hqlo.com/content/4/1/39came from a limited number of ethnic backgrounds:
Malay, Chinese, Indian and others which include Orang
Asli and Indonesian Heritage. Nevertheless, the majority
for both thalassaemia children and healthy controls were
Malays. In terms of gender, the thalassaemia group had
more males than the control group but this was not statis-
tically significant (p = 0.311).
The different types of thalassaemia and medical proce-
dures are given in Table 2. Patients were more likely to
have beta thalassaemia major, than HbE/beta thalassae-
mia and beta thalassaemia intermedia. Most of the
patients (n = 74) have not had bone marrow transplants
and have not undergone splenectomy (n = 56). 84.8%,
88.9% and 56.5% of the beta thalassaemia major patients,
beta thalassaemia intermedia patients and HbE beta tha-
lassaemia patients are respectively transfusion dependent.
We also calculated the mean serum ferritin level and the
mean dosage for the three groups. The mean serum ferri-
tin level is 4739.45 mcg/L and the mean desferal dosage is
40 mg/kg/day given for 5 days a week.
Table 3 lists mean scores of the four PedsQL 4.0 subscales
and their summarised Psychosocial Health Summary
(PCHS) and Total Summary Score (TSS) for the thalassae-
mia patients and the differences of these scores compared
to the healthy controls. The PCHS is the average of the
Emotional, Social and School Functioning, and the TSS is
the average scores of all items. The scores of three of the
PedsQL domain (Physical, Social and School function-
ing) are statistically significantly lower than those of the
healthy control with p < 0.05. The Thalassaemia subscales
score for the three domains are about 10% to 24% lower
than the healthy controls. The Thalassaemia subscale for
Emotional Functioning is lower by 2.3% and it is found to
be not statistically significant with p > 0.05. The scores for
emotional functioning of thalassaemia patients with
mean of 68.14 and sd of 17.22 is low in comparison to
scores for emotional functioning of chronically ill chil-
dren in other studies; for example, Varni et al [15]
reported that the mean (sd) for emotional functioning of
oncology patients which include acute lymphocytic leu-
kaemia, brain tumour, non Hodgkin lymphoma, Hodg-
kin lymphoma and other cancer was 71.83 (21.44).
Upton et al [19] later reported the means (sd) for emo-
tional functioning of asthma, cancer and diabetic patients
were 70.66 (20.06), 73.56 (18.39) and 78.85 (18.28) cor-
respondingly. Unexpectedly, the score for emotional func-
tioning of healthy controls in this study is equivalently
low; mean (sd) is 69.72(17.71) and it is lower than scores
for healthy children in other studies, namely, Varni et al
[15,16] reported means of 80.8 and 79.45 with sd of
19.64 and 18.00 respectively for healthy children in the
US. Upton et al [19] reported mean of 78.49 with sd of
17.94 for healthy children in the UK. The PCHS and TSS
scores for the thalassaemia are also about 12% to 14%
lower than the healthy controls and these are found to be
statistically significant (p < 0.05).
The results of the matched control analysis are given in
Table 4. Similar results to Table 3 were obtained. Physical
functioning, social functioning and school functioning of
Table 3: Mean Unadjusted PedsQL 4.0 Generic Quality of Life Scores in Thalassaemia patients compared to Healthy Schoolchildren
Domain Thalassaemia 
Patients (n = 78)
Healthy Controls 
(n = 235)
Difference 95% Confidence Interval 
of the Difference
P-Value
Physical Functioning 69.15 (16.45) 84.84 (13.04) -15.69 (-19.75 to -11.63) <0.001
Emotional Functioning 68.14 (17.22) 69.72 (17.71) -1.58 (-6.10 to 2.94) 0.492
Social Functioning 74.29 (18.77) 82.36 (15.87) -8.07 (-12.34 to -3.78) <0.001
School Functioning 60.14 (16.41) 79.21 (15.75) -19.08 (-23.27 to -14.88) <0.001
Psychosocial Health Summary 67.58 (12.77) 77.09 (13.12) -9.52 (-12.99 to -6.04) <0.001
Total Summary Score 68.91 (12.12) 79.79 (11.60) -10.88 (-14.11 to 7.65) <0.001
Values are presented as Mean (SD)
Table 2: Thalassaemia types and medical procedures among Thalassaemia patients
Types of Thalassaemia All (n = 78) Number with >8 blood transfusions per 
year (Transfusion Dependent)
1. Beta Thalassaemia Major 46 (59.0) 39 (84.8)
2. Beta Thalassaemia Intermedia 9 (11.5) 8 (88.9)
3. HbE Beta Thalassaemia 23 (29.5) 13 (56.5)
Other medical procedures
4. Have had bone marrow transplant 4 (5.1)
5. Have had splenectomy 22 (28.2)
Values are presented as number (percentage).Page 4 of 8
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The emotional functioning of the patients is similar to
previous results which is slightly lower than the healthy
controls and again found to be not statistically significant.
We reran the analysis, excluding patients who have had
bone marrow transplants in another match control analy-
sis by age and gender and we obtained similar results to
table 3.
A multiple regression analysis was carried out to adjust for
imbalances in age, sex, ethnicity and household income.
The model is statistically significant for all domains except
for Emotional Functioning (Table 5). An investigation of
whether there were any interactions between predictors
for the four scores, in which a significant difference
showed only for school functioning did Age and Thalas-
saemia status interact. The fitted lines for School Func-
tioning by age are shown in Figure 1 for Thalassaemia and
Non Thalassaemia (Healthy Controls). It shows that the
healthy controls start higher but decreases as they get
older but the thalassaemia patients remain low through-
out, so the effect of thalassaemia appears less for the older
children. The difference in slope between the cases and
controls is 1.298, 95%CI (0.193 to 2.402) with p value
<0.001 and R adj = 0.263.
Discussion
The assessment of quality of life in children especially in
children with chronic illness such as thalassaemia is par-
ticularly important. If they survive the illness, children not
only have longer lives to lead compared to adults, but they
are less able to voice their concerns and are more vulnera-
ble than adults.
The use of self report health-related quality of life ques-
tionnaires in the assessment of thalassaemia patients can
help identify the impact of the disease and its associated
treatments from the children's perspective [20]. There
have also been discussions among paediatricians and
child health researchers about the importance of chil-
dren's perspectives on their own health. A recent study
found that children as young as six years old can ade-
quately understand and accurately report their own health
and well being [21]. Vincent and Higginson [22] stressed
that any measurement of the quality of life of children
should include questions on physical, social and psycho-
logical functioning of a child. They also emphasised that
educational achievement, questions on sexuality, social
and peer acceptance become significantly important as
the children grow older especially during adolescent.
The PedsQL 4.0 Generic Core Scale self report was chosen
by the team as the research instrument as it incorporates
the dimensions necessary for measuring the HRQoL of
paediatric population and has been tested for validity and
reliability in both physically healthy paediatric popula-
tions and in paediatric acute and chronic health condi-
tions [14-16].
There has not been previous study to compare the the
HRQoL of thalassaemia patients to healthy children. This
is the first study to provide evidence that the HRQoL of
thalassaemia patients is lower than the HRQoL of healthy
controls. The effect of thalassaemia on the HRQoL of
these children is to reduce their physical, social and
school functioning by about 10% to 24%. This was con-
firmed through our matched control analysis (Table 4).
Although the unadjusted emotional functioning scores
Table 5: Adjusted Difference in the Quality of Life Scores between Thalassaemia Children and Healthy Controls
Domains Regression Coefficients 
(Thalassaemia Status (ThalS)
95% CI P values Adjusted R squared
Physical Functioning -15.690 (-19.279 to -12.100) <0.001 0.192
Emotional Functioning -1.582 (-6.106 to 2.941) 0.4920
Social Functioning -8.067 (-12.345 to -3.789) <0.001 0.039
Table 4: Results from matched study
Domain Thalassaemia 
Patients (n = 70)
Healthy Controls 
(n = 70)
Difference 95% Confidence Interval of 
the Difference
P-Value
Physical Functioning 69.17 (15.34) 85.49 (12.67) -16.43 (-21.19 to -11.67) <0.001
Emotional Functioning 68.14 (16.75) 70.36 (16.86) -2.21 (-6.89 to 2.47) 0.349
Social Functioning 73.29 (18.69) 82.21 (15.29) -8.93 (-14.34 to -3.51) <0.05
School Functioning 59.86 (16.60) 80.00 (14.40) -20.14 (-25.53 to -14.76) <0.05
Psychosocial Health Summary 67.39 (13.24) 77.58 (12.63) -10.19 (-14.18 to -6.21) <0.001
Total Summary Score 67.70 (12.49) 79.51 (11.90) -11.81 (-15.63 to -8.00) <0.001
Values are presented as Mean (SD)Page 5 of 8
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counterpart, a multiple regression analysis adjusting for
age, gender, ethnicity and household income shows that
the adjusted effect of thalassaemia on their emotional
functioning is small and not statistically significant (Table
5). Pakbaz et al [11] earlier suggested that emotional func-
tioning is one of the impaired domains of thalassaemia
patients and this study shows that thalassaemia patients
scored low in their emotional functioning (Tables 3 and
4). Interestingly, a study by Tsiantis et al [23] also suggests
that thalassaemia patients have their own coping strate-
gies in dealing with their life but these coping strategies
are not examined in this study. It is also discovered that
the healthy controls in this study score equally low in
their emotional functioning. The score is lower than
healthy samples in the United States [15,16] and in the
UK [19]. The healthy controls are from urban areas in a
developing country and are known to have hectic life-
styles. They go to school with heavy bags full of stationary
and books that weigh sometimes up to 5 kg; involved in
extra curricular activities (effectively stay at school up to
10 hours a day); early evening go for private tuitions. All
these factors could aggravate their emotional functioning.
This result hence warrants further research on healthy
children across the country so a conclusive perspective
could be arrived. As for this study, the result suggests that
the difference between the thalassaemia children and the
healthy controls is quite marginal and this is their own
self-reported views within the context of Malaysia.
The results of the investigation of interaction terms in the
multiple regression analysis show that school functioning
Impact of different Ages on School Functioning for Thalassaemia Children And Healthy ControlsFigure 1
Impact of different Ages on School Functioning for Thalassaemia Children And Healthy Controls.
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these children is lower than the controls and remain low
throughout their life. This seems to prove that having to
go to hospital for blood transfusions is one of the main
reasons that thalassaemia patients are missing school and
this is affecting their HRQoL [6,7]. Further studies should
be conducted to investigate if missing school affects their
performance in pursuing a good education as suggested
earlier by Canatan et al [24]. The Psychosocial Health
Summary scores of the thalassaemias are also lower than
the healthy controls. This finding seems to support previ-
ous studies on psychosocial aspects of thalassemia that
more psychosocial support should be given to thalassae-
mia patients [25,26].
The study also reveal that thalassaemia has different
impact at different ages on school functioning. However,
age does not have much impact on the other domains.
Gender, ethnicity and household income seem not to
have effect on the HRQoL of thalassaemia patients.
The limitation of this study is that it is conducted at only
one Thalassaemia Day Care Centre in one hospital in
Malaysia, and so, it might not be representative of the
population of Thalassaemia patients in the country. Nev-
ertheless, it is worth mentioning that the hospital is the
national referral centre for thalassaemia and amongst the
three big hospitals in Klang Valley, Malaysia with the
greatest number of children with thalassaemia. It is also
the first hospital in Malaysia to provide free desferal for
the treatment of excess iron in the body of patients due to
blood transfusion.
Conclusion
From this study, we are able to conclude that the quality
of life of thalassaemia patients is indeed much lower than
the quality of life of healthy controls regardless of age,
gender, ethnicity and household income. It is highly rec-
ommended that the Ministry of Health of Malaysia con-
tinue supporting free desferal to these patients. These
patients also need the understanding and support espe-
cially from the health authorities, policy makers, Ministry
of Education Malaysia, school authorities and the society
to provide them better quality of life.
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